cathyy smith

About the author

Our company is a globally operating service provider and one of the world leaders in the development and delivery of advanced drug therapies for rare disease. Over the years, we have worked to innovate the way modern drug discovery works, contributing to improving the health and well-being of many people around the world.

Animal Tests for Emotion-Related Behavior in Rodents

In the field of scientific research, understanding and studying emotion-related behaviors in animals plays a crucial role in advancing the knowledge of the human...

Viral Vector Characterization: Why and How

Why need viral vector characterization?Cell and gene therapies for various rare diseases are currently undergoing clinical trials worldwide. The rapid development in this field...

Rare Disease Research Challenges and Innovations

What is a rare disease?A rare disease, also known as an orphan disease, is a medical condition that affects a small number of people....

Nucleic Acid and Plasmid Analysis for Rare Diseases

Characterization of plasmids or nucleic acid constructs is fundamental to the development of gene therapy approaches. We are committed to providing automated and highly...

Development of Gene Therapy Viral Vectors for Rare Diseases

In many cases, gene therapy requires a vector to deliver the gene therapy drug to the target cell. Viral vectors have been one of...